Mitochondrial iron overload: Causes and consequences

Current Opinion in Genetics and Development

Volumn 38, Issue , 2016, Pages 31-37

  Rouault, Tracey A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; HEME; IRON; MITOCHONDRIAL PROTEIN; MITOFERRIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BIOGENESIS; CELL NUCLEUS; CYTOSOL; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXTRACELLULAR MATRIX; GENETIC DISORDER; HEME SYNTHESIS; HUMAN; IRON BALANCE; IRON OVERLOAD; IRON STORAGE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; RESPIRATORY CHAIN; REVIEW; GENETICS; HOMEOSTASIS; METABOLISM; MITOCHONDRION; PATHOLOGY; PROTEIN SYNTHESIS; SIDEROBLASTIC ANEMIA;

ANEMIA, SIDEROBLASTIC; CYTOSOL; HOMEOSTASIS; HUMANS; IRON; IRON OVERLOAD; MITOCHONDRIA; PROTEIN BIOSYNTHESIS;

EID: 84961832231     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2016.02.004     Document Type: Review

References (76)

1. Lane N., Martin W. The energetics of genome complexity. Nature 2010, 467:929-934.
2. Brown A., Amunts A., Bai X.C., Sugimoto Y., Edwards P.C., Murshudov G., Scheres S.H., Ramakrishnan V. Structure of the large ribosomal subunit from human mitochondria. Science 2014, 346:718-722.
3. Vinothkumar K.R., Zhu J., Hirst J. Architecture of mammalian respiratory complex I. Nature 2014, 515:80-84.
4. Sazanov L.A. A giant molecular proton pump: structure and mechanism of respiratory complex I. Nat Rev Mol Cell Biol 2015, 16:375-388.
5. Rouault T.A. Mammalian iron-sulphur proteins: novel insights into biogenesis and function. Nat Rev Mol Cell Biol 2015, 16:45-55.
6. Lill R., Srinivasan V., Muhlenhoff U. The role of mitochondria in cytosolic-nuclear iron-sulfur protein biogenesis and in cellular iron regulation. Curr Opin Microbiol 2014, 22C:111-119.
7. Pandey A., Golla R., Yoon H., Dancis A., Pain D. Persulfide formation on mitochondrial cysteine desulfurase: enzyme activation by a eukaryote-specific interacting protein and Fe-S cluster synthesis. Biochem J 2012, 448:171-187.
8. Shi R., Proteau A., Villarroya M., Moukadiri I., Zhang L., Trempe J.F., Matte A., Armengod M.E., Cygler M. Structural basis for Fe-S cluster assembly and tRNA thiolation mediated by IscS protein-protein interactions. PLoS Biol 2010, 8:e1000354.
9. Marinoni E.N., de Oliveira J.S., Nicolet Y., Raulfs E.C., Amara P., Dean D.R., Fontecilla-Camps J.C. (IscS-IscU)2 complex structures provide insights into Fe2S2 biogenesis and transfer. Angew Chem Int Ed Engl 2012, 51:5439-5442.
10. Shi Y., Ghosh M., Kovtunovych G., Crooks D.R., Rouault T.A. Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis. Biochim Biophys Acta 2012, 1823:484-492.
11. Sheftel A.D., Stehling O., Pierik A.J., Elsasser H.P., Muhlenhoff U., Webert H., Hobler A., Hannemann F., Bernhardt R., Lill R. Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesis. Proc Natl Acad Sci U S A 2010, 107:11775-11780.
12. Fox N.G., Das D., Chakrabarti M., Lindahl P.A., Barondeau D.P. Frataxin accelerates [2Fe-2S] cluster formation on the human Fe-S assembly complex. Biochemistry 2015, 54:3880-3889.
13. Fox N.G., Chakrabarti M., McCormick S.P., Lindahl P.A., Barondeau D.P. The human iron-sulfur assembly complex catalyzes the synthesis of [2Fe-2S] clusters on ISCU2 that can be transferred to acceptor molecules. Biochemistry 2015, 54:3871-3879.
14. Vickery L.E., Cupp-Vickery J.R. Molecular chaperones HscA/Ssq1 and HscB/Jac1 and their roles in iron-sulfur protein maturation. Crit Rev Biochem Mol Biol 2007, 42:95-111.
15. Maio N., Singh A., Uhrigshardt H., Saxena N., Tong W.H., Rouault T.A. Cochaperone binding to LYR motifs confers specificity of iron sulfur cluster delivery. Cell Metab 2014, 19:445-457.
16. Ghosh M.C., Zhang L., Rouault T.A. Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins. Neurobiol Dis 2015.
17. Lane D.J., Merlot A.M., Huang M.L., Bae D.H., Jansson P.J., Sahni S., Kalinowski D.S., Richardson D.R. Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease. Biochim Biophys Acta 2015, 1853:1130-1144.
18. Palmieri F. Mitochondrial transporters of the SLC25 family and associated diseases: a review. J Inherit Metab Dis 2014, 37:565-575.
19. Shaw G.C., Cope J.J., Li L., Corson K., Hersey C., Ackermann G.E., Gwynn B., Lambert A.J., Wingert R.A., Traver D., et al. Mitoferrin is essential for erythroid iron assimilation. Nature 2006, 440:96-100.
20. Amigo J.D., Yu M., Troadec M.B., Gwynn B., Cooney J.D., Lambert A.J., Chi N.C., Weiss M.J., Peters L.L., Kaplan J., et al. Identification of distal cis-regulatory elements at mouse mitoferrin loci using zebrafish transgenesis. Mol Cell Biol 2011, 31:1344-1356.
21. Kispal G., Csere P., Guiard B., Lill R. The ABC transporter Atm1p is required for mitochondrial iron homeostasis. FEBS Lett 1997, 418:346-350.
22. Lee J.Y., Yang J.G., Zhitnitsky D., Lewinson O., Rees D.C. Structural basis for heavy metal detoxification by an Atm1-type ABC exporter. Science 2014, 343:1133-1136.
23. Srinivasan V., Pierik A.J., Lill R. Crystal structures of nucleotide-free and glutathione-bound mitochondrial ABC transporter Atm1. Science 2014, 343:1137-1140.
24. Korolnek T., Hamza I. Like iron in the blood of the people: the requirement for heme trafficking in iron metabolism. Front Pharmacol 2014, 5:126.
25. Rouault T.A., Tong W.H. Iron-sulfur cluster biogenesis and human disease. Trends Genet 2008, 24:398-407.
26. Crooks D.R., Ghosh M.C., Haller R.G., Tong W.H., Rouault T.A. Posttranslational stability of the heme biosynthetic enzyme ferrochelatase is dependent on iron availability and intact iron-sulfur cluster assembly machinery. Blood 2010, 115:860-869.
27. Huang M.L., Becker E.M., Whitnall M., Rahmanto Y.S., Ponka P., Richardson D.R. Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proc Natl Acad Sci U S A 2009, 106:16381-16386.
28. Crooks D.R., Natarajan T.G., Jeong S.Y., Chen C., Park S.Y., Huang H., Ghosh M.C., Tong W.H., Haller R.G., Wu C., Rouault T.A. Elevated FGF21 secretion, PGC-1alpha and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle. Hum Mol Genet 2014, 23:24-39.
29. Puccio H., Simon D., Cossée M., Criqui-Filipe P., Tiziano F., Melki J., Hindelang C., Matyas R., Rustin P., Koenig M. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001, 27:181-186.
30. Navarro J.A., Botella J.A., Metzendorf C., Lind M.I., Schneuwly S. Mitoferrin modulates iron toxicity in a Drosophila model of Friedreich's ataxia. Free Radic Biol Med 2015, 85:71-82.
31. Wofford J.D., Lindahl P.A. Mitochondrial iron-sulfur cluster activity and cytosolic iron regulate iron traffic in Saccharomyces cerevisiae. J Biol Chem 2015, 290:26968-26977.
32. Invernizzi R., Travaglino E., Della Porta M.G., Gallì A., Malcovati L., Rosti V., Bergamaschi G., Erba B.G., Bellistri F., Bastia R., et al. Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors. Br J Haematol 2013, 161:726-737.
33. Malcovati L., Cazzola M. Refractory anemia with ring sideroblasts. Best Pract Res Clin Haematol 2013, 26:377-385.
34. Malcovati L., Karimi M., Papaemmanuil E., Ambaglio I., Jädersten M., Jansson M., Elena C., Gallì A., Walldin G., Della Porta M.G., et al. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 2015, 126:233-241.
35. Whitnall M., Suryo Rahmanto Y., Huang M.L., Saletta F., Lok H.C., Gutiérrez L., Lázaro F.J., Fleming A.J., St Pierre T.G., Mikhael M.R., et al. Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia. Proc Natl Acad Sci U S A 2012, 109:20590-20595.
36. Pain D., Dancis A. Fe-S assembly and regulation in yeast. Iron Sulfur Clusters in Proteins and Chemistry 2014, 367-410. deGruyter, Berlin. T.A. Rouault (Ed.).
37. Zutz A., Gompf S., Schägger H., Tampé R. Mitochondrial ABC proteins in health and disease. Biochim Biophys Acta 2009, 1787:681-690.
38. Cabantchik Z.I., Munnich A., Youdim M.B., Devos D. Regional siderosis: a new challenge for iron chelation therapy. Front Pharmacol 2013, 4:167.
39. Maio N., Ghezzi D., Verrigni D., Rizza T., Bertini E., Martinelli D., Zeviani M., Sing Maio N., Ghezzi D., Verrigni D., Rizza T., Bertini E., Martinelli D., Zeviani M., Singh A., Carrozzo R., Rouault T.A. Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB. Cell Metab 2016, 23:292h-302h.
40. Campuzano V., Montermini L., Molto M.D., Pianese L., Cossee M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996, 271:1423-1427.
41. Babcock M., de Silva D., Oaks R., Davis-Kaplan S., Jiralerspong S., Montermini L., Pandolfo M., Kaplan J. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 1997, 276:1709-1712.
42. Puccio H., Simon D., Cossée M., Criqui-Filipe P., Tiziano F., Melki J., Hindelang C., Matyas R., Rustin P., Koenig M. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001, 27:181-186.
43. Wingert R.A., Galloway J.L., Barut B., Foott H., Fraenkel P., Axe J.L., Weber G.J., Dooley K., Davidson A.J., Schmid B., et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 2005, 436:1035-1039.
44. Camaschella C., Campanella A., De Falco L., Boschetto L., Merlini R., Silvestri L., Levi S., Iolascon A. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 2007, 110:1353-1358.
45. Ye H., Jeong S.Y., Ghosh M.C., Kovtunovych G., Silvestri L., Ortillo D., Uchida N., Tisdale J., Camaschella C., Rouault T.A. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. J Clin Invest 2010, 120:1749-1761.
46. Larsson L.E., Linderholm H., Mueller R., Ringqvist T., Soernaes R. Hereditary metabolic myopathy with paroxysmal myoglobinuria due to abnormal glycolysis. J Neurol Neurosurg Psychiatry 1964, 27:361-380.
47. Haller R.G., Henriksson K.G., Jorfeldt L., Hultman E., Wibom R., Sahlin K., Areskog N.H., Gunder M., Ayyad K., Blomqvist C.G., et al. Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defect. J Clin Invest 1991, 88:1197-1206.
48. Mochel F., Knight M.A., Tong W.H., Hernandez D., Ayyad K., Taivassalo T., Andersen P.M., Singleton A., Rouault T.A., Fischbeck K.H., Haller R.G. Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance. Am J Hum Genet 2008, 82:652-660.
49. Olsson A., Lind L., Thornell L.E., Holmberg M. Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect. Hum Mol Genet 2008, 17:1666-1672.
50. Kollberg G., Tulinius M., Melberg A., Darin N., Andersen O., Holmgren D., Oldfors A., Holme E. Clinical manifestation and a new ISCU mutation in iron-sulphur cluster deficiency myopathy. Brain 2009, 132:2170-2179.
51. Schmitz-Abe K., Ciesielski S.J., Schmidt P.J., Campagna D.R., Rahimov F., Schilke B.A., Cuijpers M., Rieneck K., Lausen B., Linenberger M.L., et al. Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9. Blood 2015, Recent discovery that mutations of the HSP70 human homologues, HSPA9 are a cause of sideroblastic anemia, as expected based on yeast studies.
52. Maio N., Singh A., Uhrigshardt H., Saxena N., Tong W.H., Rouault T.A. Cochaperone binding to LYR motifs confers specificity of iron sulfur cluster delivery. Cell Metab 2014, 19:445-457.
53. Farhan S.M.K., Wang J., Robinson J.F., Lahiry P., Siu V.M., Prasad C., Kronick J.B., Ramsay D.A., Rupar C.A., Hegele R.A. Exome sequencing identifies deficiency in a novel Fe-S cluster disease, infantile mitochondrial complex II/III deficiency. Mol Genet Genomic Med 2014, 2:73-80.
54. Li J., Kogan M., Knight S.A., Pain D., Dancis A. Yeast mitochondrial protein, Nfs1p, coordinately regulates iron-sulfur cluster proteins, cellular iron uptake, and iron distribution. J Biol Chem 1999, 274:33025-33034.
55. Lim S.C., Friemel M., Marum J.E., Tucker E.J., Bruno D.L., Riley L.G., Christodoulou J., Kirk E.P., Boneh A., DeGennaro C.M., et al. Mutations in LYRM4, encoding iron-sulfur cluster biogenesis factor ISD11, cause deficiency of multiple respiratory chain complexes. Hum Mol Genet 2013, 22:4460-4473.
56. Wiedemann N., Urzica E., Guiard B., Muller H., Lohaus C., Meyer H.E., Ryan M.T., Meisinger C., Muhlenhoff U., Lill R., Pfanner N. Essential role of Isd11 in mitochondrial iron-sulfur cluster synthesis on Isu scaffold proteins. EMBO J 2006, 25:184-195.
57. Adam A.C., Bornhovd C., Prokisch H., Neupert W., Hell K. The Nfs1 interacting protein Isd11 has an essential role in Fe/S cluster biogenesis in mitochondria. EMBO J 2006, 25:174-183.
58. Lee J.Y., Yang J.G., Zhitnitsky D., Lewinson O., Rees D.C. Structural basis for heavy metal detoxification by an Atm1-type ABC exporter. Science 2014, 343:1133-1136.
59. Srinivasan V., Pierik A.J., Lill R. Crystal structures of nucleotide-free and glutathione-bound mitochondrial ABC transporter Atm1. Science 2014, 343:1137-1140.
60. Allikmets R., Raskind W.H., Hutchinson A., Schueck N.D., Dean M., Koeller D.M. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 1999, 8:743-749.
61. Bottomley S.S., May B.K., Cox T.C., Cotter P.D., Bishop D.F. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia. J Bioenerg Biomembr 1995, 27:161-168.
62. Bottomley S.S., Fleming M.D. Sideroblastic anemia: diagnosis and management. Hematol Oncol Clin North Am 2014, 28:653-670.
63. May A., Bishop D.F. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia. Haematologica 1998, 83:56-70.
64. Caudill J.S., Imran H., Porcher J.C., Steensma D.P. Congenital sideroblastic anemia associated with germline polymorphisms reducing expression of FECH. Haematologica 2008, 93:1582-1584.
65. Guernsey D.L., Jiang H., Campagna D.R., Evans S.C., Ferguson M., Kellogg M.D., Lachance M., Matsuoka M., Nightingale M., Rideout A., et al. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet 2009, 41:651-653.
66. An W., Zhang J., Chang L., Zhang Y., Wan Y., Ren Y., Niu D., Wu J., Zhu X., Guo Y. Mutation analysis of Chinese sporadic congenital sideroblastic anemia by targeted capture sequencing. J Hematol Oncol 2015, 8:55. Recent confirmation that SLC25A38 mutations cause sideroblastic anemia in Chinese.
67. Bayeva M., Khechaduri A., Wu R., Burke M.A., Wasserstrom J.A., Singh N., Liesa M., Shirihai O.S., Langer N.B., Paw B.H., Ardehali H. ATP-binding cassette B10 regulates early steps of heme synthesis. Circ Res 2013, 113:279-287.
68. Yamamoto M., Arimura H., Fukushige T., Minami K., Nishizawa Y., Tanimoto A., Kanekura T., Nakagawa M., Akiyama S., Furukawa T. Abcb10 role in heme biosynthesis in vivo: Abcb10 knockout in mice causes anemia with protoporphyrin IX and iron accumulation. Mol Cell Biol 2014, 34:1077-1084.
69. Bykhovskaya Y., Casas K., Mengesha E., Inbal A., Fischel-Ghodsian N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 2004, 74:1303-1308.
70. Mueller E.G., Ferre-D'Amare A.R. Pseudouridine formation, the most common transglycosylation in RNA. Madame Curie Biosci. Database 2000, http://www.ncbi.nlm.nih.gov/books/NBK6205/%3ABookshelf%20ID%3ANBK6205.
71. Schwartz S., Bernstein D.A., Mumbach M.R., Jovanovic M., Herbst R.H., León-Ricardo B.X., Engreitz J.M., Guttman M., Satija R., Lander E.S., et al. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell 2014, 159:148-162.
72. Metodiev M.D., Assouline Z., Landrieu P., Chretien D., Bader-Meunier B., Guitton C., Munnich A., Rötig A. Unusual clinical expression and long survival of a pseudouridylate synthase (PUS1) mutation into adulthood. Eur J Hum Genet 2015, 23:880-882.
73. Riley L.G., Cooper S., Hickey P., Rudinger-Thirion J., McKenzie M., Compton A., Lim S.C., Thorburn D., Ryan M.T., Giege R., et al. Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia - MLASA syndrome. Am J Hum Genet 2010, 87:52-59.
74. Sasarman F., Nishimura T., Thiffault I., Shoubridge E.A. A novel mutation in YARS2 causes myopathy with lactic acidosis and sideroblastic anemia. Hum Mutat 2012, 33:1201-1206.
75. Shahni R., Wedatilake Y., Cleary M.A., Lindley K.J., Sibson K.R., Rahman S. A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations. Am J Med Genet A 2013, 161A:2334-2338.
76. Burrage L.C., Tang S., Wang J., Donti T.R., Walkiewicz M., Luchak J.M., Chen L.C., Schmitt E.S., Niu Z., Erana R., et al. Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G > A) in the mitochondrial encoded ATP6 gene. Mol Genet Metab 2014, 113:207-212.